Table 3.
Costs used in the model*
| Cost variable | References | |
|---|---|---|
| IMAI Assessment, $ per test | ||
| Labor | 1.02 | J. A. Crump, pers. comm., 2014,16 |
| Total | 1.02 | |
| Laboratory assessment for sepsis | ||
| Negative blood culture, $ per test | J. A. Crump, pers. comm., 2014 | |
| Reagents and Supplies | 6.20 | |
| Labor | 2.27 | |
| Indirect costs | 1.79 | |
| Equipment | 1.15 | |
| Total cost negative blood culture | 11.41 | |
| Positive blood culture, $ per test | J. A. Crump, pers. comm., 2014 | |
| Reagents and supplies | 10.26 | |
| Labor | 6.85 | |
| Indirect costs | 1.79 | |
| Equipment | 1.15 | |
| Subtotal | 20.05 | |
| ID and susceptibilities, $ per test | J. A. Crump, pers. comm., 2014 | |
| Reagents and supplies | 44.02 | |
| Labor | 6.10 | |
| Indirect costs | 1.79 | |
| Subtotal | 51.91 | |
| Total cost positive blood culture | 71.96 | |
| Cost of antimicrobial treatment, $ per case | 7,17 | |
| Generic antimicrobials | ||
| Emergency dose | 0.59 | |
| Standard treatment | 12.63 | |
| Total cost generic antimicrobials | 13.22 | |
| Evidence-based antimicrobials, $ per case | ||
| Emergency dose | 4.41 | |
| Standard treatment | 22.05 | |
| Total cost evidence-based antimicrobials | 26.46 | |
IMAI = Integrated Management of Adolescent and Adult Illness.
Costs adjusted to 2011 U.S. dollars ($) values using gross domestic product (GDP) deflator.